[Current situation and features of chemotherapy for breast neoplasms].
Yamashita
Toshinari
T
Department of Breast Oncology, Aichi Cancer Center Hospital.
Iwata
Hiroji
H
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D016190:Carboplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D043823:Taxoids / Q000008:administration & dosage; D000068878:Trastuzumab; D000093542:Gemcitabine
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D043823:Taxoids; D003841:Deoxycytidine; D016190:Carboplatin; D000068878:Trastuzumab; D000093542:Gemcitabine